Cargando…

DNTTIP2 Expression is Associated with Macrophage Infiltration and Malignant Characteristics in Low-Grade Glioma

PURPOSE: Low-grade gliomas (LGG) are primary brain tumors that often affect predominantly young adults, which usually have a painless course, and have a longer survival period compared to patients with high-grade gliomas. Relatively established treatment options include surgery, radiotherapy, chemot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yuan-Jie, Zeng, Shu-hong, Qian, Wei-hua, Tao, Min-xian, Zhu, Ying-ying, Li, Jie-pin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965469/ https://www.ncbi.nlm.nih.gov/pubmed/35370417 http://dx.doi.org/10.2147/PGPM.S356326

Ejemplares similares

DNTTIP1 is a Prognostic Biomarker Correlated With Immune Infiltrates in Hepatocellular Carcinoma: A Study Based on The Cancer Genome Atlas Data
por: Zhu, Changyu, et al.
Publicado: (2022)

Polo-like kinase 1 is related with malignant characteristics and inhibits macrophages infiltration in glioma
por: Luo, Lin, et al.
Publicado: (2022)

SAMD9 Is Relating With M2 Macrophage and Remarkable Malignancy Characters in Low-Grade Glioma
por: Ma, Wenping, et al.
Publicado: (2021)

High Expression of DNTTIP1 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Wang, Xuegang, et al.
Publicado: (2023)

Protective Prognostic Biomarkers Negatively Correlated with Macrophage M2 Infiltration in Low-Grade Glioma
por: Zhu, Yunyang, et al.
Publicado: (2022)

Identification of 3 subpopulations of tumor-infiltrating immune cells for malignant transformation of low-grade glioma
por: Lu, Jiacheng, et al.
Publicado: (2019)

Berberine protects hepatocyte from hypoxia/reoxygenation-induced injury through inhibiting circDNTTIP2
por: Zhu, Yi, et al.
Publicado: (2023)

DNTTIP1 promotes nasopharyngeal carcinoma metastasis via recruiting HDAC1 to DUSP2 promoter and activating ERK signaling pathway
por: Ding, Shirong, et al.
Publicado: (2022)

Advanced imaging in adult diffusely infiltrating low-grade gliomas
por: Bulakbaşı, Nail, et al.
Publicado: (2019)

Analysis of Clinical Characteristics and Risk Factors of Postoperative Recurrence and Malignant Transformation of Low-Grade Glioma
por: Luo, Cheng, et al.
Publicado: (2022)

Correction to: Advanced imaging in adult diffusely infiltrating low-grade gliomas
por: Bulakbaşı, Nail, et al.
Publicado: (2020)

Comprehensive Analysis of Ferroptosis Regulators with Regard to PD-L1 and Immune Infiltration in Low-Grade Glioma
por: Luan, Yuxuan, et al.
Publicado: (2023)

Characterization of the Ferroptosis-Related Genes for Prognosis and Immune Infiltration in Low-Grade Glioma
por: Yan, Xiuwei, et al.
Publicado: (2022)

Uncovering the Immune Cell Infiltration Landscape in Low-Grade Glioma for Aiding Immunotherapy
por: Yang, Youyuan, et al.
Publicado: (2022)

Elevated RECQL1 expression predicts poor prognosis and associates with tumor immune infiltration in low-grade glioma
por: Wang, Guiyuan, et al.
Publicado: (2022)

Spatial distribution of malignant transformation in patients with low-grade glioma
por: Jakola, Asgeir S., et al.
Publicado: (2020)

Retracted: Analysis of Clinical Characteristics and Risk Factors of Postoperative Recurrence and Malignant Transformation of Low-Grade Glioma
por: Oncology, Journal of
Publicado: (2023)

Comprehensive Analysis of Inflammatory Response–Related Genes, and Prognosis and Immune Infiltration in Patients With Low-Grade Glioma
por: Han, Tao, et al.
Publicado: (2021)

ADPRH is a prognosis-related biomarker and correlates with immune infiltrates in low grade glioma
por: Zhang, Chunyu, et al.
Publicado: (2021)

New prognostic biomarker CMTM3 in low grade glioma and its immune infiltration
por: Li, Shoubin, et al.
Publicado: (2022)

PTPRN Serves as a Prognostic Biomarker and Correlated with Immune Infiltrates in Low Grade Glioma
por: Li, Peng, et al.
Publicado: (2022)

FSTL3 is a Prognostic Biomarker in Gastric Cancer and is Correlated with M2 Macrophage Infiltration
por: Liu, Yuan-Jie, et al.
Publicado: (2021)

The Eclectic Nature of Glioma-Infiltrating Macrophages and Microglia
por: Arrieta, Víctor A., et al.
Publicado: (2021)

EFEMP2 indicates assembly of M0 macrophage and more malignant phenotypes of glioma
por: Huang, Lijie, et al.
Publicado: (2020)

An MRI radiomics approach to predict survival and tumour-infiltrating macrophages in gliomas
por: Li, Guanzhang, et al.
Publicado: (2022)

Identification of RUNX1 and IFNGR2 as prognostic-related biomarkers correlated with immune infiltration and subtype differentiation of low-grade glioma
por: Zhang, Xia, et al.
Publicado: (2023)

Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma
por: Lu, Jiajie, et al.
Publicado: (2021)

Identification of Autophagy-Related Prognostic Signature and Analysis of Immune Cell Infiltration in Low-Grade Gliomas
por: Quan, Qingli, et al.
Publicado: (2021)

EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma
por: Hao, Yong-Ping, et al.
Publicado: (2021)

Phosphatase and Tensin Homolog Mutation in Immune Cell Infiltration and Clinicopathological Features of Low-Grade Gliomas
por: Feng, Peng, et al.
Publicado: (2020)

Immunological and prognostic analysis of PSENEN in low-grade gliomas: An immune infiltration-related prognostic biomarker
por: Chen, Kaijie, et al.
Publicado: (2022)

Construction of immune cell infiltration protein network based on clinical low grade glioma cases
por: Jiang, Wei, et al.
Publicado: (2022)

High-expression of Galactosidase alpha is correlated with poor prognosis and immune infiltration in low-grade glioma
por: Zhang, Yi, et al.
Publicado: (2023)

Construction of ceRNA networks with different types of IDH1 mutation status in low-grade glioma patients
por: Wang, Wen-Jie, et al.
Publicado: (2022)

Utility of Nuclear Morphometry in Predicting Grades of Diffusely Infiltrating Gliomas
por: Boruah, Dibyajyoti, et al.
Publicado: (2013)

Heterogeneity in clinical prognosis, immune infiltration and molecular characteristics of three glycolytic subtypes in lower-grade gliomas
por: Wu, Shenglian, et al.
Publicado: (2023)

Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy
por: Teng, Chubei, et al.
Publicado: (2022)

TUBA1C is a Prognostic Marker in Low-grade Glioma and Correlates with Immune Cell Infiltration in the Tumor Microenvironment
por: Zhu, Hua, et al.
Publicado: (2021)

Management of Low-Grade Glioma
por: Pouratian, Nader, et al.
Publicado: (2010)

Pediatric Low-Grade Gliomas
por: Collins, Kelly L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vuumoqn6hklbabcd5ac16csa18